Thomas Sciascia
Founder bei TREVI THERAPEUTICS, INC.
Vermögen: 706 067 $ am 31.03.2024
Profil
Thomas R.
Sciascia is the founder and the Chief Science Officer at Trevi Therapeutics, Inc., a company founded in 2011.
He previously worked as a Medical Director at Quintiles, Inc. (California) from 1997 to 2000, and at Transkaryotic Therapies, Inc. from 2000 to 2001.
He also served as the Chief Medical Officer & Senior Vice President at Penwest Pharmaceuticals Co. from 2001 to 2010.
Prior to his industry experience, he was a Faculty Member at Boston University from 1983 to 1997.
Dr. Sciascia holds a doctorate degree from The Trustees of Columbia University in The City of New York, conferred in 1979, and an undergraduate degree from Massachusetts Institute of Technology, conferred in 1975.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
TREVI THERAPEUTICS, INC.
0,30% | 15.02.2024 | 204 657 ( 0,30% ) | 706 067 $ | 31.03.2024 |
Aktive Positionen von Thomas Sciascia
| Unternehmen | Position | Beginn |
|---|---|---|
| TREVI THERAPEUTICS, INC. | Founder | 01.01.2011 |
Ehemalige bekannte Positionen von Thomas Sciascia
| Unternehmen | Position | Ende |
|---|---|---|
Transkaryotic Therapies, Inc.
 Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01.01.2001 |
Quintiles, Inc. (California)
 Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Chief Tech/Sci/R&D Officer | 01.01.2000 |
| Boston University | Corporate Officer/Principal | 01.01.1997 |
Penwest Pharmaceuticals Co.
 Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Thomas Sciascia
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| Massachusetts Institute of Technology | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TREVI THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Commercial Services |
Penwest Pharmaceuticals Co.
Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY. | Health Technology |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Health Services |
